MRNA Free Cash Flow Growth

Moderna · Free Cash Flow Growth

MRNA logo

MRNA Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported65.06%
MRNA TTM Free Cash Flow YoY % (-11.99% → 65.06%)
High-resolution chart · PNG

MRNA free cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Moderna Free Cash Flow Growth — Trailing twelve months (TTM)
Period endingFree Cash Flow Growth
65.0571%
60.7833%
49.3465%
32.6845%
12.0382%
-9.8584%
-6.0131%
-48.8897%
-427.7188%
-700%
-183.4971%
-142.8479%
-108.1823%
-95.3035%
-65.6494%
-45.5431%
1.4483%
160.2069%
580.5738%
1,748.237%
2,547.609%
1,209.3889%
499.4771%
225.0345%
23.5344%
-1.4735%
-12.3425%
-10.2678%
-17.7348%
-3.0866%
-11.9897%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.